Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells-Reference-Cited by-同舟云学术

Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells

Published:2023-03 Issue:3 Volume:42 Page:112241
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Li Suwen,Wang Chloe S.,Montel-Hagen Amélie,Chen Ho-Chung,Lopez Shawn,Zhou Olivia,Dai Kristy,Tsai Steven,Satyadi William,Botero Carlos,Wong Claudia,Casero David,Crooks Gay M.,Seet Christopher S.^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference84 articles.

1. CAR T cell immunotherapy for human cancer;June;Science,2018

2. From pluripotent stem cells to T cells;Montel-Hagen;Exp. Hematol.,2019

3. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy;Themeli;Nat. Biotechnol.,2013

4. Function of novel anti-CD19 chimeric antigen receptors with human variable regions is affected by hinge and transmembrane domains;Alabanza;Mol. Ther.,2017

5. Tonic 4-1BB costimulation in chimeric antigen receptors impedes T cell survival and is vector-dependent;Gomes-Silva;Cell Rep.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy;Clinical and Translational Medicine;2024-09

2. Adoptive Cell Therapy from the Dish: Potentiating Induced Pluripotent Stem Cells;Transfusion Medicine and Hemotherapy;2024-08-26

3. Rediscovering the human thymus through cutting-edge technologies;Journal of Experimental Medicine;2024-08-21

4. Rebuilding and rebooting immunity with stem cells;Cell Stem Cell;2024-05

5. Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation;Frontiers in Immunology;2024-01-12